NCT07222579
- Conditions
- CD19 Positive, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- West Virginia University Cancer Institute Morgantown, West Virginia, United States
Clinical trial condition
CD19 Positive
Explore clinical trials studying CD19 Positive. Study availability and eligibility vary by location and protocol.
6 public trials
1 recruiting study
CD19 Positive trial results
Active, not recruiting
Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
NCT04007029
- Conditions
- CD19 Positive, CD20 Positive, Chronic Disease, +33 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Active, not recruiting
Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies
NCT03241940
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CD19 Positive, +29 more
- Locations
-
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
Active, not recruiting
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies
NCT03233854
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CD19 Positive, +22 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
Active, not recruiting
Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia
NCT03512405
- Conditions
- CD19 Positive, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT02529813
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, +28 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States